285 related articles for article (PubMed ID: 26150517)
1. ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis.
Jin S; Chen J; Chen L; Histen G; Lin Z; Gross S; Hixon J; Chen Y; Kung C; Chen Y; Fu Y; Lu Y; Lin H; Cai X; Yang H; Cairns RA; Dorsch M; Su SM; Biller S; Mak TW; Cang Y
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9088-93. PubMed ID: 26150517
[TBL] [Abstract][Full Text] [Related]
2. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Seo W; Gao Y; He Y; Sun J; Xu H; Feng D; Park SH; Cho YE; Guillot A; Ren T; Wu R; Wang J; Kim SJ; Hwang S; Liangpunsakul S; Yang Y; Niu J; Gao B
J Hepatol; 2019 Nov; 71(5):1000-1011. PubMed ID: 31279903
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
Abe H; Aida Y; Seki N; Sugita T; Tomita Y; Nagano T; Itagaki M; Sutoh S; Nagatsuma K; Itoh K; Matsuura T; Aizawa Y
J Gastroenterol Hepatol; 2015 Sep; 30(9):1376-83. PubMed ID: 25778454
[TBL] [Abstract][Full Text] [Related]
4. [Association between aldehyde dehydrogenase-2/cytochrome P450 2E1 genetic polymorphism and habit of alcohol drinking and the susceptibility of hepatocellular carcinoma].
Ye X; Peng T; Liu T; Su Z; Xiao K; Shang L; Su M; Li L
Wei Sheng Yan Jiu; 2010 Jan; 39(1):42-5. PubMed ID: 20364586
[TBL] [Abstract][Full Text] [Related]
5. Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.
Matsumura Y; Li N; Alwaseem H; Pagovich OE; Crystal RG; Greenblatt MB; Stiles KM
Hum Gene Ther; 2020 Feb; 31(3-4):163-182. PubMed ID: 31801381
[TBL] [Abstract][Full Text] [Related]
6. Transformed ALDH2
Zhang XN; Meng FG; Wang YR; Liu SX; Zeng T
Med Hypotheses; 2021 Jan; 146():110366. PubMed ID: 33208242
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.
Kwon HJ; Won YS; Park O; Chang B; Duryee MJ; Thiele GE; Matsumoto A; Singh S; Abdelmegeed MA; Song BJ; Kawamoto T; Vasiliou V; Thiele GM; Gao B
Hepatology; 2014 Jul; 60(1):146-57. PubMed ID: 24492981
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians.
Zhou D; Xiao L; Zhang Y; Xian J; Jiang J; Zong W; Huang Z; Yang Y
Tumour Biol; 2012 Jun; 33(3):841-6. PubMed ID: 22231434
[TBL] [Abstract][Full Text] [Related]
9. The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases.
Wu YC; Yao Y; Tao LS; Wang SX; Hu Y; Li LY; Hu S; Meng X; Yang DS; Li H; Xu T
Cell Signal; 2023 Feb; 102():110550. PubMed ID: 36464104
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice.
Hirohashi K; Ohashi S; Amanuma Y; Nakai Y; Ida T; Baba K; Mitani Y; Mizumoto A; Yamamoto Y; Kikuchi O; Matsubara J; Yamada A; Miyamoto S; Seno H; Matsuda T; Muto M
Carcinogenesis; 2020 Apr; 41(2):194-202. PubMed ID: 31074772
[TBL] [Abstract][Full Text] [Related]
11. Alcohol metabolism and cardiovascular response in an alcoholic patient homozygous for the ALDH2*2 variant gene allele.
Chen YC; Lu RB; Peng GS; Wang MF; Wang HK; Ko HC; Chang YC; Lu JJ; Li TK; Yin SJ
Alcohol Clin Exp Res; 1999 Dec; 23(12):1853-60. PubMed ID: 10630602
[TBL] [Abstract][Full Text] [Related]
12. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway.
Xia P; Liu DH; Wang D; Wen GM; Zhao ZY
Free Radic Biol Med; 2023 Sep; 206():125-133. PubMed ID: 37406742
[TBL] [Abstract][Full Text] [Related]
13. Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion.
Steinmetz CG; Xie P; Weiner H; Hurley TD
Structure; 1997 May; 5(5):701-11. PubMed ID: 9195888
[TBL] [Abstract][Full Text] [Related]
14. Diminished alcohol preference in transgenic mice lacking aldehyde dehydrogenase activity.
Isse T; Oyama T; Kitagawa K; Matsuno K; Matsumoto A; Yoshida A; Nakayama K; Nakayama K; Kawamoto T
Pharmacogenetics; 2002 Nov; 12(8):621-6. PubMed ID: 12439222
[TBL] [Abstract][Full Text] [Related]
15. ALDH2 Polymorphism and Ethanol Consumption: A Genetic-Environmental Interaction in Carcinogenesis.
Yang M; Zhang Y; Ren J
Adv Exp Med Biol; 2019; 1193():229-236. PubMed ID: 31368108
[TBL] [Abstract][Full Text] [Related]
16. Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency.
Montel RA; Munoz-Zuluaga C; Stiles KM; Crystal RG
Cancer Gene Ther; 2022 Jul; 29(7):889-896. PubMed ID: 34799722
[TBL] [Abstract][Full Text] [Related]
17. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant.
Crabb DW; Edenberg HJ; Bosron WF; Li TK
J Clin Invest; 1989 Jan; 83(1):314-6. PubMed ID: 2562960
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-week ethanol feeding on the liver of aldehyde dehydrogenase 2 knockout mice.
Matsumoto A; Kawamoto T; Mutoh F; Isse T; Oyama T; Kitagawa K; Nakayama KI; Ichiba M
Pharmacogenet Genomics; 2008 Oct; 18(10):847-52. PubMed ID: 18704003
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde Dehydrogenase, Liver Disease and Cancer.
Wang W; Wang C; Xu H; Gao Y
Int J Biol Sci; 2020; 16(6):921-934. PubMed ID: 32140062
[TBL] [Abstract][Full Text] [Related]
20. Gene Therapy Correction of Aldehyde Dehydrogenase 2 Deficiency.
Matsumura Y; Stiles KM; Reid J; Frenk EZ; Cronin S; Pagovich OE; Crystal RG
Mol Ther Methods Clin Dev; 2019 Dec; 15():72-82. PubMed ID: 31649957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
